Top Tweets for #IGaN
IgA Nephropathy #IgAN: Pathophysiology and Mechanistic Targets ๐ฏ of Potential Novel Therapies from @goKDIGO
#Nephpearls
๐ https://t.co/Eb3BaeBzUh
@VertexPharma has joined the REIGNITE Study as a funding collaborator. REIGNITE is an international registry aiming to enroll 6,000+ patients with biopsy-confirmed IgA nephropathy to close real-world evidence gaps in #IgAN. Learn more: https://t.co/berdCBYvoP
IgAN+ just won Gold.
Our app for people living with IgAN and their care partners earned Gold for Health & Wellness and Silver for Best User Experience at the 2026 W3 Awards.
Built with our community and AGP.
https://t.co/j42X1abPJf
#Igan #Iganplusapp #Iganephropathy
Doors are now open at IgAN Horizons. It's 9 AM ET. Join us, explore the platform, and connect with peers before Welcome Remarks at 9:30 AM ET. Can't join live? Sessions will be available on demand.
https://t.co/iJl4F5XH3V
#IgANHorizons #IgAN
Treatment with maximally tolerated RAASi alone does not sufficiently slow the rate of eGFR decline in high-risk patients with IgA nephropathy #IgAN, leaving patients at risk of ESKD ca. 2026 from @DrAnjayRastogi @asnpublications
#Nephpearls
๐ These findings underscore the need for disease-modifying therapies capable of effectively preserving kidney function, particularly in this predominantly young patient population
๐ https://t.co/X5IwDS04n9
Travere to Present New Data Supporting FILSPARIยฎ (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026 - For More Information Visit https://t.co/owQ4FK6fMM @TravereRare #IgAN #IgA_Nephropathy #Rare_Diseases #Orphan_Drugs
1/4 eGFR slope is now a common outcome in #IgAN trials and KDIGO has proposed a treatment target of <1 mL/min/1.73mยฒ/year decline.
We asked: could we predict a patientโs future eGFR slope to identify risk of progression earlier?โจhttps://t.co/NF8cENBEzb
@NavTangri @SevenOaksCDIC
Some projects feel special from the start โญ๏ธSo grateful to be working with Dr. Glassock @GlassockJ on an exciting initiative #GlomerularDisease. Can't wait to build something meaningful together ๐๐ป
#RareKidneyDisease #IgAN
Adults with #IgAN are at greater risk of adverse kidney outcomes versus nonglomerular CKD and substantially higher risks of heart failure and death compared with no CKD ca. 2026 from @KIReports
#Nephpearls #RKDSummit
๐๐ผ https://t.co/ZcpIXW2TvQ
Dipstick hemoglobinuria is associated with histologic markers of active disease in #IgAN and may provide clinically relevant information to complement current assessment of disease activity in #IgAN ca. 2026 from @Kidney_Int @LadanZand @fervenzaf
#Nephpearls #RKDSummit
๐๐ผ https://t.co/NtxaDs0YtT
Microscopic hematuria as a risk factor for #IgAN progression: considering this biomarker in selecting and monitoring patients ca. 2023 from @LadanZand @fervenzaf
#Nephpearls #RKDSummit
๐๐ผ https://t.co/2uWJ8miYNV
๐จ Latest news in #IgAN!
Sefaxersen achieved statistically significant and clinically meaningful reductions in proteinuria vs placebo at week 37 in the phase III IMAgINATION study.
By inhibiting hepatic production of complement factor B, sefaxersen targets a key driver of complement activation in IgA nephropathy ๐งฌ
#Nephrology #Complement #IgAN #GlomerularDiseases #ClinicalTrials
๐ https://t.co/5wq000CYBG
Delphi panels are a powerful way to capture expert consensus; though they take real time, #discipline & #teamwork to do right. Proud of our team on this one โญ๏ธ๐ฅ
#IgAN is evolving fast; another Delphi post-#ASN feels inevitable ๐
#RareKidneyDisease #RKD #GlomerularDiseases
๐ https://t.co/Q7aiTlOrno
@AKronbichler @kidneybiz @BradRovin @SWadhwaniMD @jradnephro @Madanef30 โญ๏ธ๐ฅ๐๐ป@GlomCon
Dr. Rhee @ConnieMRhee presented important data on #IgAN
Also look at what it comes up when you google her name!! โMaking history as the first female EIC @JASN_News #CJASN ๐ ๐ฅ
A combination of Iptacopan+MMF + low dose steroids @UpToDate for patients with severe disease with crescents and progression @GlassockJ
#IgAN #RareKidneydisease
Dr. Zuckerman @JZRenalPath fantastic talk on #IgAN pathology.
Inflammatory/hypercellularity within the segmental sclerosing lesion could be a good prognostic factor๐ฅ
โMost patients who makes it to your office will have lost half of their nephrons already.โ- Prof Jonathan Barrett addressing the audience at #WUSTLNeph Glom Conference 2026 on #IgAN @Ting2li
Last Seen Hashtags on Sotwe
PMV
Seen from Russia
teenageer
Seen from United States
ometv
Seen from United States
hospital porn
Seen from Turkey
ๅๆขๅตใณใใณ
Seen from United Kingdom
bop
Seen from United States
minichat
Seen from Indonesia
walkabouttown
Seen from United States
minichat()()()()*+filter:videos
Seen from United Kingdom
snapchat
Seen from Netherlands
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.9M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers